HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

One-dose antibiotic prophylaxis against wound infection after appendicectomy: a randomized trial of clindamycin, cefazolin sodium and a placebo.

Abstract
Two hundred and fifty patients were admitted to a prospective randomized trial of single dosage prophylaxis against wound infection after appendicectomy. There were 12 exclusions, 72 patients received placebo, 81 received 600 mg i.m. clindamycin phosphate and 85 received 1 1 g i.m. cefazolin sodium, the agent being given in the anaesthetic room. Clindamycin produced a significant reduction in the overall rate of wound infection from 33 per cent in the controls to 17 per cent. In cases with a gangrenous or perforated appendix the infection rate in controls was 78 per cent; this was reduced to 44 per cent by a single dose of clindamycin. Cefazolin significantly reduced the number of aerobic organisms isolated from wound infections, but did not significantly reduce the incidence of wound infection. We conclude that anaerobic organisms are more important than faecal aerobic organisms in the pathogenesis of wound infection after appendicectomy.
AuthorsI A Donovan, D Ellis, D Gatehouse, G Little, R Grimley, S Armistead, M R Keighley, C J Strachan
JournalThe British journal of surgery (Br J Surg) Vol. 66 Issue 3 Pg. 193-6 (Mar 1979) ISSN: 0007-1323 [Print] England
PMID371743 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Cephalosporins
  • Placebos
  • Clindamycin
  • Cefazolin
Topics
  • Adult
  • Aged
  • Appendectomy (adverse effects)
  • Cefazolin (administration & dosage, therapeutic use)
  • Cephalosporins (therapeutic use)
  • Clindamycin (administration & dosage, therapeutic use)
  • Clinical Trials as Topic
  • Humans
  • Placebos
  • Postoperative Period
  • Random Allocation
  • Surgical Wound Infection (microbiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: